Navigation Links
Marrone Bio Innovations Named an IC20 Company

DAVIS, Calif., Nov. 18 /PRNewswire/ -- Marrone Bio Innovations (MBI), a leader in the discovery, development and commercialization of effective and environmentally responsible pest management products, announced that it has been named an IC20 company by the Investors' Circle, the United States' oldest and largest national angel investing group.

Companies named to the IC20 excel in performance leading to rewarding results for all stakeholders, including investors, the environment and society. Qualitative and quantitative metrics are used to assess 197 companies, identifying the top achievers in financial, social, and environmental success.

"MBI's selection as an IC20 company recognizes our commitment to bringing effective, natural, environmentally sound pest management products to the marketplace," states Pam Marrone, Founder and CEO of MBI. "Our success comes from solving our customers unmet needs, and providing safe, effective products to replace and augment disappearing synthetic alternatives. Our mission inherently benefits the environment, and our success rewards those who have contributed financially to our growth and achievements, such as the Investors' Circle."

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products, including two insecticides, two herbicides and Zequanox(TM), a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI currently markets Regalia® for control of fungal and bacterial diseases of both food and ornamental crops, and GreenMatch® Burndown Herbicide for weed control in organic crop production.

Investors' Circle is a network of over 225 angel investors, professional venture capitalists, foundations, family offices and others who are using private capital to promote the transition to a sustainable economy. Since 1992, Investors' Circle has facilitated the flow of over $133 million into more than 200 companies and small funds addressing social and environmental issues.

SOURCE Marrone Bio Innovations

SOURCE Marrone Bio Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
2. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results
3. The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
5. Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
6. Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
7. Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
8. Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance
9. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
10. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
11. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
Post Your Comments:
(Date:11/30/2015)... NORTH CHICAGO, Ill. , Nov. 30, 2015 /PRNewswire/ ... an all-inclusive program that focuses on a daily routine ... how patients take their medication can affect the way ... establish and follow to their a daily routine are ... is to help patients better manage their hypothyroidism ...
(Date:11/30/2015)... TIKVAH, Israel , Nov. 30, 2015 /PRNewswire/ ... a leading developer of adult stem cell technologies for neurodegenerative ... Ltd., has been awarded an additional grant of approximately $735,000 ... Scientist (OCS). This grant, the second this year, brings the ... approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... India , November 27, 2015 /PRNewswire/ ... --> Growing popularity of companion diagnostics ... in cancer biomarkers market with pharmaceutical companies ... in-demand companion diagnostic tests. ... --> Complete report on global cancer ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... EASTON, Mass. , Nov. 17, 2015 ... a leader in the development and sale of broadly ... the worldwide life sciences industry, today announced it has ... of its $5 million Private Placement (the "Offering"), increasing ... to $4,025,000.  One or more additional closings are expected ...
Breaking Biology News(10 mins):